Stocks

Rapid risers (past year)

  • INTC · Intel Corp
    a year ago$17.97now$99.17+452%
    market value$511.4B

    Intel designs and manufactures computer processor chips used in PCs, servers, and data centers.

    why Intel experienced a massive ~453% rally over the past year, as noted directly in the headline 'Intel Just Experienced a Monster 453% Rally. Is It Time to Sell or Double Down?', though the provided headlines do not explain the underlying reason for the surge. source

    Analysts are cautiously neutral — the massive run-up is noted but conviction to chase it remains low, with a Hold consensus.

  • AMD · Advanced Micro Devices Inc
    a year ago$105.70now$466.38+341%
    market value$771.3B

    Advanced Micro Devices makes computer processors and graphics chips for PCs, gaming consoles, and data centers.

    why The provided headlines do not explain AMD's ~341% rise; the headlines reference AVGO, broad market moves, and AI innovation ETFs but contain no AMD-specific explanation for the move.

    Analysts are broadly bullish — strong Buy consensus suggests the AI-driven momentum is seen as fundamentally justified.

  • GOOGL · Alphabet Inc
    a year ago$166.40now$368.53+122%
    market value$4.47T

    Alphabet runs Google Search, YouTube, and a major cloud computing business.

    why Google's stock likely rose in part due to a major $30 billion computing power deal struck with SpaceX, signaling strong AI infrastructure demand and a significant commercial partnership. source

    Analysts are very enthusiastic — near-unanimous Buy consensus reflects confidence in its AI integration and advertising recovery.

  • QCOM · Qualcomm Inc
    a year ago$132.69now$215.94+63%
    market value$230.7B

    Qualcomm designs wireless chips and licenses mobile technology used in smartphones and connected devices.

    why Qualcomm faced headwinds as Nvidia was reported to be moving into Intel and Qualcomm's turf, raising concerns about increased competition in Qualcomm's core markets. source

    Analysts are lukewarm despite the strong run — a Hold consensus suggests the market may have already priced in the good news.

  • AVGO · Broadcom Inc
    a year ago$240.40now$385.73+61%
    market value$1.88T

    Broadcom designs semiconductors and software for networking, storage, and wireless communications.

    why Broadcom's stock rose over the past year driven by its premium AI-related valuation and analyst expectations of up to 50% further upside, reflecting strong investor interest in its AI and semiconductor business. source

    Analysts are firmly bullish — strong Buy consensus backs the view that its AI networking exposure still has room to run.

  • NVDA · NVIDIA Corp
    a year ago$133.12now$205.10+54%
    market value$5.03T

    NVIDIA makes graphics processing units and AI accelerator chips widely used in data centers and gaming.

    why The provided headlines do not contain an NVDA-specific explanation for its ~54% rise; the Intel rally headline mentions Nvidia only in the context of Intel's performance, and no headline directly addresses Nvidia's own annual gain.

    Analysts are overwhelmingly bullish — near-unanimous Buy consensus treats it as the defining pick of the AI hardware boom.

  • AAPL · Apple Inc
    a year ago$200.29now$307.34+54%
    market value$4.58T

    Apple designs and sells iPhones, Macs, and other consumer devices alongside a growing services business.

    why Apple's stock rose toward all-time highs over the past year, with investor excitement building around the anticipated launch of AI-powered Siri features expected to be unveiled at WWDC. source

    Analysts lean bullish — solid Buy consensus reflects confidence in its services growth and AI-enhanced product cycle.

  • MRK · Merck & Co Inc
    a year ago$78.61now$120.79+54%
    market value$302.3B

    Merck develops and sells prescription medicines and vaccines, including its blockbuster cancer drug Keytruda.

    why The provided headlines focus almost entirely on smaller biotech companies (AGEN, ERAS) and general healthcare seasonality, and do not contain a Merck-specific explanation for its ~54% rise.

    Analysts are broadly bullish — Buy consensus points to strong pipeline confidence and durable revenue from key drugs.

  • JNJ · Johnson & Johnson
    a year ago$156.31now$232.77+49%
    market value$563.6B

    Johnson and Johnson develops pharmaceuticals and medical devices sold globally.

    why The provided headlines do not contain a Johnson & Johnson-specific explanation for its ~49% rise; the most relevant headline merely notes J&J backed an $85M funding round for CereVasc, which is not sufficient to explain a year-long gain of that magnitude.

    Analysts lean bullish — Buy consensus reflects optimism around its pharmaceutical pipeline following its consumer health spinoff.

  • ORCL · Oracle Corp
    a year ago$151.98now$213.68+41%
    market value$619.0B

    Oracle provides database software and cloud computing services to businesses worldwide.

    why The provided headlines do not contain an Oracle-specific explanation for its ~41% rise; Oracle is mentioned only in a headline about upcoming market events ('SpaceX IPO, Apple, Oracle Loom') without detail on what drove the annual gain.

    Analysts are bullish — Buy consensus suggests the market believes its cloud infrastructure build-out is accelerating meaningfully.

Sources: Finnhub — live quotes, returns, analyst ratings